EYEN
Eyenovia, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Michael M. Rowe
IPO Date
2018-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Eyenovia, Inc.
CEO
Michael M. Rowe
IPO Date
2018-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 0 |
| $0.00 |
| 3 Jun 2025 | Avenue Capital Management II, L.P. | 10 percent owner | Disposed | 2,327,747 | $2.15 |
| 29 Apr 2025 | Ianchulev Tsontcho | director | A-Award | Acquired | 5,000 | $0.00 |
| 29 Apr 2025 | Strahlman Ellen R | director | A-Award | Acquired | 3,000 | $0.00 |
| 29 Apr 2025 | MATHER CHARLES E IV | director | A-Award | Acquired | 8,000 | $0.00 |
| 23 Apr 2025 | Ianchulev Tsontcho | director | A-Award | Acquired | 5,000 | $0.00 |
| 23 Apr 2025 | Strahlman Ellen R | director | A-Award | Acquired | 3,000 | $0.00 |
| 23 Apr 2025 | MATHER CHARLES E IV | director | A-Award | Acquired | 8,000 | $0.00 |
| 3 Sept 2024 | Jones Andrew D. | Chief Financial Officer | A-Award | Acquired | 200,000 | $0.55 |